Amyloidosis Research Foundation


Home






Amyloidosis
Manager ™

Clinical trials are a crucial part of the search for improved diagnoses and treatments for amyloidosis.  Clinical trials rely upon the participation of patients and their families.  While the patient may or may not benefit from a new or investigational treatment, the information learned from their participation will certainly help others.

Most clinical trials are registered with the National Institute of Health (NIH).  Sites where clinical trial information can be found are:

www.clinicaltrials.gov is a service of the NIH

Another site to find trials for AL amyloidosis is www.cancer.gov/clinicaltrials provided by the National Cancer Institute.  At this site select multiple myeloma as the type of cancer and primary systemic amyloidosis as the subtype

Announcing New Trials Recruiting Patients

The Effect of Diflunisal on Familial Amyloidosis

Boston University School of Medicine

 

Memorial Sloan-Kettering Clinical Trials

 

Phase I/II Study of Human Immune Globulin Intravenous in Patients with Cardiac-Dominant AL Amyloidosis

University of Tennessee – Graduate School of Medicine
Knoxville, TN
Alan Solomon, MD – Principal Investigator.

Eligibility Criteria

Patients must have AL amyloidosis with cardiac involvement
Prior treatment is not a disqualifier for eligibility
Patients must be able to visit the clinic in Knoxville every week for the first 3 months, then every 2 weeks for 9 months
There is no charge for the immune globulin.  All other costs for evaluations, lab tests and medications must be covered by the patient/insurer

For more information contact Dr. Alan Solomon at 865-544-9165 or [email protected]


Safety and Efficacy Study of Fx-1006A in Patients with Familial Amyloid Polyneuropathy (FAP)

 

Mayo Clinic, Rochester, MN Clinical Trials

Mayo Clinic, Rochester, MN

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients with
Primary Systemic Amyloidosis

Purpose: This phase II trial is studying how well giving lenalidomide together with
cyclophosphamide and dexamethasone works in treating patients with primary systemic
amyloidosis.

Contact: Clinical Trials Office – Mayo Clinic 507-538-7623

 

Other Active Clinical Trials for AL Amyloidosis

 

Other Active Clinical Trials for ATTR Amyloidosis

 

Other Clinical Trials for AA Amyloidosis

 

This website designed and maintained by IGD Solutions Corporation
  1. pintarbersamamedan.org
  2. https://pintarbersamamanado.org
  3. https://pintarbersamasorong.org/dana
  4. TOGEL
  5. https://elk-mountain.com/